Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OXILVER is a line of over-the-counter topical cosmetic and therapeutic products developed by Enikam for skin and nail care. The product line includes sprays and gels formulated with active oxygen compounds derived from medical-grade hydrogen peroxide, ionized (colloidal) silver, panthenol, hyaluronic acid, and aloe vera. Its mechanism of action relies on the release of active oxygen to provide antiseptic and oxidative effects, which help oxygenate and regenerate skin and nail cells. The ionized silver works synergistically with the active oxygen to enhance its efficacy. OXILVER is marketed for conditions such as nail fungal infections, brittle or damaged nails, acne-prone skin, and irritated or cracked skin.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OXILVER.